Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CIPLA vs TEVA PHARMA (Israel) - Comparison Results

TEVA PHARMA (Israel)
   Change

Teva Pharmaceuticals, established in 1901, is a global pharmaceutical company. The company is into development, production and marketing of a wide range of specialty medicines, generic and OTC products, active pharmaceutical ingredients (API) and nov... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 CIPLA   TEVA PHARMA
EQUITY SHARE DATA
    CIPLA
Mar-23
TEVA PHARMA
Dec-13
CIPLA/
TEVA PHARMA
5-Yr Chart
Click to enlarge
High Rs1,1853,479-   
Low Rs8523,022-   
Sales per share (Unadj.) Rs281.91,996.4-  
Earnings per share (Unadj.) Rs35.1124.7-  
Cash flow per share (Unadj.) Rs49.7286.1-  
Dividends per share (Unadj.) Rs8.50109.18-  
Avg Dividend yield %0.83.4 24.8%  
Book value per share (Unadj.) Rs289.22,217.6-  
Shares outstanding (eoy) m807.15848.00-   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x3.61.6 221.9%   
Avg P/E ratio x29.026.1 111.3%  
P/CF ratio (eoy) x20.511.4 180.6%  
Price / Book Value ratio x3.51.5 240.3%  
Dividend payout %24.287.5 27.6%   
Avg Mkt Cap Rs m822,1642,756,220 29.8%   
No. of employees `000NA44.9 0.0%   
Total wages/salary Rs m38,3010-   
Avg. sales/employee Rs Th037,667.6-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th02,353.1-  
INCOME DATA
Net Sales Rs m227,5311,692,969 13.4%  
Other income Rs m5,1210-   
Total revenues Rs m232,6531,692,969 13.7%   
Gross profit Rs m48,079463,620 10.4%  
Depreciation Rs m11,721136,844 8.6%   
Interest Rs m1,09533,253 3.3%   
Profit before tax Rs m40,384293,523 13.8%   
Minority Interest Rs m01,333 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m0-192,682 -0.0%   
Tax Rs m12,029-3,584 -335.7%   
Profit after tax Rs m28,355105,758 26.8%  
Gross profit margin %21.127.4 77.2%  
Effective tax rate %29.8-1.2 -2,439.7%   
Net profit margin %12.56.2 199.5%  
BALANCE SHEET DATA
Current assets Rs m168,0511,143,425 14.7%   
Current liabilities Rs m50,333997,163 5.0%   
Net working cap to sales %51.78.6 598.9%  
Current ratio x3.31.1 291.2%  
Inventory Days Days7391 80.7%  
Debtors Days Days796 6.8%  
Net fixed assets Rs m117,318552,961 21.2%   
Share capital Rs m1,6144,167 38.7%   
"Free" reserves Rs m231,8450-   
Net worth Rs m233,4601,880,567 12.4%   
Long term debt Rs m0865,653 0.0%   
Total assets Rs m290,0673,868,976 7.5%  
Interest coverage x37.99.8 385.3%   
Debt to equity ratio x00.5 0.0%  
Sales to assets ratio x0.80.4 179.3%   
Return on assets %10.23.6 282.6%  
Return on equity %12.15.6 216.0%  
Return on capital %17.84.9 360.3%  
Exports to sales %22.60-   
Imports to sales %8.90-   
Net fx Rs m44,0800-   
CASH FLOW
From Operations Rs m32,377269,772 12.0%  
From Investments Rs m-23,885-95,591 25.0%  
From Financial Activity Rs m-9,583-323,609 3.0%  
Net Cashflow Rs m-968-149,429 0.6%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for TEVA PHARMA (Israel) is United States Dollars. All data has been converted at 83.34 Rs / USD

Compare CIPLA With: MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  

Compare CIPLA With: PHARMAIDS PH  KIMIA BIOSCIENCES  ELDER PHARMA  MESCO PHARMA  TYCHE INDUSTRIES  



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.